Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX
暂无分享,去创建一个
Marco Rovaris | Massimo Filippi | Christian Enzinger | Frederik Barkhof | Stefan Ropele | Paola Valsasina | David H. Miller | Hugo Vrenken | Chris H Polman | Bas Jasperse | Stephen M Smith | F. Barkhof | M. Rovaris | M. Filippi | P. Valsasina | C. Enzinger | H. Vrenken | C. Polman | V. Anderson | D. Knol | S. Ropele | A. Giorgio | Stephen M. Smith | B. Jasperse | T. Korteweg | David H Miller | Nicola De Stefano | Dirk L Knol | Antonio Giorgio | Tijmen Korteweg | Veronica Neacsu | Valerie Anderson | N. de Stefano | V. Neacsu | Dirk L. Knol | David H. Miller
[1] M. Battaglini,et al. Response to the letter “Progression of gray matter atrophy and its association with white matter lesions in relapsing–remitting multiple sclerosis” by Bendfeldt et al. , 2009, Journal of the Neurological Sciences.
[2] A Giorgio,et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis , 2009, Neurology.
[3] Marco Battaglini,et al. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis , 2009, Journal of the Neurological Sciences.
[4] A. Giorgio,et al. Impairment of vertical saccades from an acute pontine lesion in multiple sclerosis. , 2008, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[5] Heidi Johansen-Berg,et al. Imaging white matter diffusion changes with development and recovery from brain injury , 2008, Developmental neurorehabilitation.
[6] Frederik Barkhof,et al. Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. , 2007, Archives of neurology.
[7] Mark W. Woolrich,et al. Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.
[8] M Rovaris,et al. Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis , 2004, Neurology.
[9] Lluís Jover,et al. Estimating the Generalized Concordance Correlation Coefficient through Variance Components , 2003, Biometrics.
[10] Michael R. Chernick,et al. Tests of Hypotheses , 2003 .
[11] J H Simon,et al. Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.
[12] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[13] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[14] David H. Miller,et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.
[15] Marco Rovaris,et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.
[16] Massimo Filippi,et al. European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.
[17] F. Barkhof,et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.
[18] A J Thompson,et al. Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis , 1995, Neurology.